Stephen Doster

  • Vanderbilt University

    ‘Black in Cancer’ promotes diversity in research

    Oct. 21, 2020, 3:45 PM   by Tom Wilemon Black In Cancer, an initiative cofounded by Henry Henderson III, PhD, a postdoctoral researcher at Vanderbilt-Ingram Cancer Center, is making an impact just two months after its inception. Henry Henderson III, PhD “Black in Cancer Week,” held Oct. 11-17, focused… Read More

    Oct. 21, 2020

  • Vanderbilt University

    Craig Lindsley named director of Warren Center for Neuroscience Drug Discovery

    by Ryan Underwood Oct. 20, 2020, 11:50 AM Craig Lindsley, the William K. Warren, Jr. Chair in Medicine and University Professor of Pharmacology, Biochemistry and Chemistry, will become director of the Warren Center for Neuroscience Drug Discovery, effective Dec. 1. (John Russell/Vanderbilt)… Read More

    Oct. 21, 2020

  • New faculty Nancy Carrasco - Molecular Physiology, in her lab at Light Hall for Vanderbilt Magazine.

    Carrasco elected to the National Academy of Medicine

    Oct. 20, 2020, 8:45 AM by Bill Snyder Three members of the Vanderbilt University School of Medicine faculty have been elected this year to the National Academy of Medicine (NAM), the organization announced Monday, Oct. 19. They are: Nancy Carrasco, MD, professor and chair of the Department of… Read More

    Oct. 20, 2020

  • Ian Macara

    Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapy’s impact on tissue growth

    by Marissa Shapiro Oct. 15, 2020, 12:00 PM Vanderbilt University researchers have reported the counterintuitive discovery that certain chemotherapeutic agents used to treat tumors can have the opposite effect of tissue overgrowth in normal, intact mammary glands, epidermis and hair follicles. The researchers also… Read More

    Oct. 15, 2020

  • Robert J. Coffey GI Medicine/Oncology GI SPORE Cancer research

    Possible COVID-19 “decoy”

    Oct. 15, 2020, 10:00 AM by Bill Snyder The novel coronavirus, SARS-CoV-2, must bind to the cell surface receptor ACE2 to enter cells and cause infection. Recently a preclinical study by an international research team found that the presence of a recombinant soluble form of human ACE2 reduced viral growth and inhibited infection. This raises… Read More

    Oct. 15, 2020

  • Vanderbilt University

    Factor involved in stomach injury response identified

    Oct. 15, 2020, 9:09 AM by Bill Snyder Researchers at Vanderbilt University Medical Center have identified a key factor that coordinates the body’s repair response to severe injury in the stomach caused, most commonly, by infection by the bacterium Helicobacter pylori. Coordinating repair is a type of white blood cell… Read More

    Oct. 15, 2020

  • Volker Haase. Photos by Joe Howell

    Brain blood vessel response to hypoxia

    Oct. 15, 2020, 9:00 AM by Leigh MacMillan Chronic hypoxia (low oxygen) in the brain promotes neurovascular angiogenesis — growth of new blood vessels — and remodeling, but the cell types and molecular pathways involved are not completely understood. Volker Haase, MD, and… Read More

    Oct. 15, 2020

  • Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. Dr. Crowe is the subject of a feature article in the upcoming Winter 2018 issue of Vanderbilt Magazine. Crowe, who is the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology, as well as director of the Vanderbilt Vaccine Center, has spent his career hunting for a universal flu vaccine. He has re-engineered how flu vaccines work and is on the edge of creating a single shot that covers all flu strains. In a new initiative announced in October, he will lead an international team of researchers as they launch clinical trials of his new vaccine.(John Russell/Vanderbilt University)

    COVID-19 long-acting antibodies discovered by Vanderbilt University Medical Center move to phase 3 clinical trials

    Oct. 13, 2020, 1:44 PM by Bill Snyder AstraZeneca is advancing into phase 3 clinical trials with an investigational COVID-19 therapy of two long-acting antibodies discovered by Vanderbilt University Medical Center and optimized by AstraZeneca. On Oct. 9, AstraZeneca announced it received support from the U.S. government for the development… Read More

    Oct. 15, 2020

  • Matthew Lang Chemical & Biomolecular Engineering nf Photography by Mary Donaldson

    Team’s sustained work in T-cell immune response awarded P01 grant totaling $11 million

    For more than a decade Matt Lang and collaborators across the U.S. have worked to recreate key components of T-cells and how they know when to start fighting disease. Conventional wisdom suggested that T-cells formed regular, force-free bonds with infected cells, and in doing so caused the chain reaction of… Read More

    Oct. 13, 2020

  • Vanderbilt University

    Researchers create molecular ‘atlas’ of GI tract neurons

    Oct. 8, 2020, 10:28 AM Michelle Southard-Smith, PhD, Aaron May-Zhang, PhD, and colleagues have created a molecular ‘atlas’ of genes expressed by the neuronal cells within the intestine that coordinate the functions of the gastrointestinal (GI) tract. (photo by Susan Urmy) by Bill Snyder Researchers at Vanderbilt University Medical Center… Read More

    Oct. 9, 2020